Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 10:26:26 2024-07-17 am EDT			5-day change	1st Jan Change
36.54 ^EUR	+1.35%		-0.06%	-4.64%

Jul. 16	Fresenius rises - Deutsche Bank: higher annual targets possible	DP
Jul. 16	Frankfurt shares open: Political uncertainty weighs on Dax	DP

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from Barclays

January 28, 2022 at 11:24 am EST

Barclays analyst Hassan Al-Wakeel maintains his Neutral opinion on the stock. The target price is reduced from EUR 73 to EUR 70.

Latest news about Fresenius Medical Care AG

Fresenius rises - Deutsche Bank: higher annual targets possible	Jul. 16	DP
Frankfurt shares open: Political uncertainty weighs on Dax	Jul. 16	DP
US FTC probing DaVita, Fresenius Medical, Politico reports	Jul. 13	RE
FRESENIUS MEDICAL CARE : Still a long way to go	Jul. 12
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Receives a Buy rating from Goldman Sachs	Jul. 05	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS sticks Neutral	Jun. 19	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies	Jun. 14	ZD
Transcript : Fresenius Medical Care AG - Special Call	Jun. 13
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	Jun. 12	MT
Fresenius Signs Agreements With Wind, Solar Energy Project Developers in US, Germany	Jun. 12	MT
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07	RE
Optimism gives Dax a tailwind	Jun. 06	RE
Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15	Jun. 05	DP
Fresenius raises targets for hospital business - shares up	Jun. 05	DP
Fresenius raises the bar for hospital subsidiary Helios	Jun. 05	RE
Fresenius driven by higher Helios targets	Jun. 05	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	Jun. 05	ZD
Fresenius lifts 2024 targets for private healthcare unit Helios	Jun. 05	RE
Fresenius chart breakout fails before capital market day	Jun. 04	DP
Austria's state holding ÖBAG sells stake in Vamed to Fresenius	Jun. 04	RE
FMC briefly burdened by research success in the fight against diabetes	May. 28	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reaffirms its Buy rating	May. 28	ZD
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	May. 24	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating	May. 24	ZD
FMC, Fresenius and Davita rise after Ozempic news	May. 24	DP

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-07-29 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Still a long way to go

July 12, 2024 at 05:02 am EDT

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

36.05 EUR

Average target price

40 EUR

Spread / Average Target

+10.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	-4.64%	11.51B
HCA HEALTHCARE, INC.	+21.55%	83.53B
CVS HEALTH CORPORATION	-21.92%	75.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	26.73B
LABCORP HOLDINGS INC.	-3.96%	18.25B
FRESENIUS SE & CO. KGAA	+7.37%	18.12B
QUEST DIAGNOSTICS INCORPORATED	+8.65%	16.51B
NATERA, INC.	+78.37%	14.05B
TENET HEALTHCARE CORPORATION	+77.71%	13.03B
PURE HEALTH HOLDING	-27.89%	12.67B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from Barclays

EPS Revisions